Published in F1000Res on January 21, 2014
Levelling the lingo playing field. EMBO Rep (2015) 0.97
Increasing the public health potential of basic research and the scientist satisfaction. An international survey of bioscientists. F1000Res (2016) 0.84
Publishing interdisciplinary research - a perspective from the Croatian Medical Journal. Croat Med J (2015) 0.75
Rescuing US biomedical research from its systemic flaws. Proc Natl Acad Sci U S A (2014) 14.78
A vision for the future of genomics research. Nature (2003) 14.06
Separate neural systems value immediate and delayed monetary rewards. Science (2004) 13.85
How to increase value and reduce waste when research priorities are set. Lancet (2014) 9.64
Normal Misbehavior: Scientists Talk about the Ethics of Research. J Empir Res Hum Res Ethics (2006) 3.25
Science's new social contract with society. Nature (1999) 2.72
Should we make a fuss? A case for social responsibility in science. Nat Biotechnol (2005) 2.40
Evaluation of the research norms of scientists and administrators responsible for academic research integrity. JAMA (1998) 2.30
Teaching scientists to be citizens. It is hard to become a good scientist. It is even harder to become a good citizen. EMBO Rep (2003) 1.82
Predicting scientists' participation in public life. Public Underst Sci (2012) 1.65
Scientist citizens. Science (2009) 1.61
Geneticists' views on science policy formation and public outreach. Am J Med Genet A (2005) 1.53
Beyond scientific rigour: funding cancer research of public value. Health Policy (2007) 1.34
Estimating the NIH efficient frontier. PLoS One (2012) 1.20
Measuring consensus about scientific research norms. Sci Eng Ethics (2000) 1.12
Biomedical scientists' perceptions of ethical and social implications: is there a role for research ethics consultation? PLoS One (2009) 1.11
Barriers to Considering Ethical and Societal Implications of Research: Perceptions of Life Scientists. AJOB Prim Res (2012) 1.01
Scientific Citizenship and good governance: implications for biotechnology. Trends Biotechnol (2005) 0.98
Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required. J Investig Med (2006) 0.97
The "how" and "whys" of research: life scientists' views of accountability. J Med Ethics (2009) 0.93
Molecular geneticists and moral responsibility: "maybe if we were working on the atom bomb I would have a different argument. Sci Eng Ethics (1999) 0.90
Why we don't spend enough on public health. N Engl J Med (2010) 0.89
Genetic testing and its implications: human genetics researchers grapple with ethical issues. Sci Technol Human Values (2003) 0.89
Why science cannot be value-free: understanding the rationality and responsibility of science. Sci Eng Ethics (2009) 0.85
Scientific rationality, uncertainty and the governance of human genetics: an interview study with researchers at deCODE genetics. Eur J Hum Genet (2006) 0.84
Basic Blue Skies Research in the UK: Are we losing out? J Biomed Discov Collab (2008) 0.82
Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions. Naturwissenschaften (1998) 0.82
[The usefulness of useless knowledge]. Med Deporte Trab (1952) 0.78
Publications in PubMed on Ebola and the 2014 outbreak. F1000Res (2015) 1.01
Countries' Biomedical Publications and Attraction Scores. F1000Res (2014) 0.87